ARVO Annual Meeting, May 2012
Approval of new retina drugs by the US Food and Drug Administration (FDA) is contingent upon trust and belief that clinical trial data are of sufficient integrity. From database build to database lock, clinical data management (CDM), the process of collecting, cleaning, and managing subject and/or trial data in compliance with regulatory standards, is a crucial component of any clinical trial.